Search Results - "Kaviraj, Swarnendu"

This result is not displayed to guests.
Login for full access.

An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial

Saraf, Amit, Gurjar, Rohan, Kaviraj, Swarnendu, Kulkarni, Aishwarya, Kumar, Durgesh, Kulkarni, Ruta, Virkar, Rashmi, Krishnan, Jayashri, Yadav, Anjali, Baranwal, Ekta^{Aff3, Aff4}, Singh, Ajay, Raghuwanshi, Arjun, Agarwal, Praveen, Savergave, Laxman, Singh, Sanjay^{Aff1, IDs41591024029552_cor15}

Unveiling Fundamentals and Research Opportunities of mRNA Technology

Kumar, Durgesh^Aff3, Singh, Ajay^Aff3, Kaviraj, Swarnendu^Aff3, Singh, Sanjay^Aff3

John, George, editor^Aff1, Panda, Amulya K., editor^Aff2

Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19

Kumar, Durgesh^Aff1, Gaikwad, Kshitij, Gunnale, Rushank, Vishwakarma, Sandeep, Shukla, Shalu, Srivastava, Shalini, Gopal, Janhavi, Vaidya, Bhalchandra, Saraf, Amit, Gurjar, Rohan, Kaviraj, Swarnendu, Singh, Ajay, Raghuwanshi, Arjun, Agarwal, Praveen, Savergave, Laxman, Singh, Sanjay^{Aff1, IDs41541025010762_cor1}

This result is not displayed to guests.
Login for full access.

Production of leishmanin skin test antigen from Leishmania donovani for future reintroduction in the field

Dey, Ranadhir, Alshaweesh, Jalal^{Aff2, Aff3}, Singh, Kamaleshwar P., Lypaczewski, Patrick, Karmakar, Subir, Klenow, Laura, Paulini, Kayla, Kaviraj, Swarnendu, Kamhawi, Shaden, Valenzuela, Jesus G., Singh, Sanjay^{Aff4, IDs41467023427322_cor11}, Hamano, Shinjiro^{Aff2, Aff3, IDs41467023427322_cor12}, Satoskar, Abhay R.^{Aff7, IDs41467023427322_cor13}, Gannavaram, Sreenivas^{Aff1, IDs41467023427322_cor14}, Nakhasi, Hira L.^{Aff1, IDs41467023427322_cor15}, Matlashewski, Greg^{Aff5, IDs41467023427322_cor16}

Development of a process for large scale production of PfRH5 in E. coli expression system

Raghuwanshi, Arjun Singh, Kumar, Ankit, Raghuwanshi, Navdeep, Singh, Shravan Kumar, Singh, Avinash Kumar, Tripathi, Umanath, Kaviraj, Swarnendu, Singh, Sanjay

LmCen^−/− based vaccine is protective against canine visceral leishmaniasis following three natural exposures in Tunisia.

Boussoffara, Thouraya, Labidi, Imen, Trimèche, Malek, Chelbi, Ifhem, Dachraoui, Khalil, Msallem, Nourhane, Abdo Saghir Abbas, Mohammed, Cherni, Saifedine, Singh, Kamaleshwar P., Kaviraj, Swarnendu, Dey, Ranadhir, Varikuti, Sanjay, Gannavaram, Sreenivas, da S. Pereira, Lais, Zhang, Wen-Wei, Lypaczewski, Patrick, Hamano, Shinjiro, Kato, Hirotomo, Singh, Sanjay, Louzir, Hechmi

Translational development of a tumor junction opening technology

Kim, Jiho^{Aff1, Aff2}, Li, Chang, Wang, Hongjie, Kaviraj, Swarnendu, Singh, Sanjay, Savergave, Laxman, Raghuwanshi, Arjun, Gil, Sucheol, Germond, Audrey, Baldessari, Audrey, Chen, Bingmae, Roffler, Steve, Fender, Pascal, Drescher, Charles, Carter, Darrick^{Aff1, Aff2, Aff8}, Lieber, André^{Aff1, Aff9, IDs4159802211843z_cor16}

The Plasmodium falciparum circumsporozoite protein produced in Lactococcus lactis is pure and stable

Singh, Susheel K., Plieskatt, Jordan, Chourasia, Bishwanath Kumar, Singh, Vandana, Bolscher, Judith M. ^**, Dechering, Koen J. ^**, Adu, Bright, López-Méndez, Blanca, Kaviraj, Swarnendu, Locke, Emily, King, C. Richter, Theisen, Michael

Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis

Karmakar, Subir, Ismail, Nevien, Oliveira, Fabiano, Oristian, James, Zhang, Wen Wei, Kaviraj, Swarnendu, Singh, Kamaleshwar P., Mondal, Abhishek, Das, Sushmita, Pandey, Krishna, Bhattacharya, Parna, Volpedo, Greta, Gannavaram, Sreenivas, Satoskar, Monika, Satoskar, Sanika, Sastry, Rajiv M., Oljuskin, Timur, Sepahpour, Telly, Meneses, Claudio, Hamano, Shinjiro^{Aff7, Aff8}, Das, Pradeep, Matlashewski, Greg^Aff3, Singh, Sanjay^Aff4, Kamhawi, Shaden^Aff2, Dey, Ranadhir^Aff1, Valenzuela, Jesus G.^Aff2, Satoskar, Abhay^Aff6, Nakhasi, Hira L.^Aff1

Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial

Singh, Kavita, Mukherjee, Paushali, Shakri, Ahmad Rushdi, Singh, Ankita, Pandey, Gaurav^{Aff1, Aff3}, Bakshi, Meenakshi, Uppal, Geetanjali, Jena, Rajender, Rawat, Ankita, Kumar, Purnima, Bhardwaj, Rukmini, Yazdani, Syed Shams, Hans, Dhiraj, Mehta, Shantanu, Srinivasan, Ajay, Anil, K., Madhusudhan, R. L., Patel, Jaya, Singh, Amit, Rao, Rajeshwar, Gangireddy, Santosh, Patil, Rudrappa, Kaviraj, Swarnendu, Singh, Sanjay, Carter, Darrick, Reed, Steve, Kaslow, David C., Birkett, Ashley, Chauhan, Virander S., Chitnis, Chetan E.^{Aff2, Aff8}

This result is not displayed to guests.
Login for full access.

The variable quality of commercial E. coli L-Asparaginases in India and the implications for clinical practice

Sidhu, Jasmeet, Gogoi, Manash Pratim, Bose, Priyanka, Kumar, Nidhi Satish., Saha, Debparna, Paul, Pritha, Bhagwat, Shivani, Saha, Vaskar, Kaviraj, Swarnendu, Agarwal, Praveen, Mukherjee, Tathagata, Krishnan, Shekhar

This result is not displayed to guests.
Login for full access.

Elucidation of molecular mechanism of stability of the heme-regulated eIF2α kinase upon binding of its ligand, hemin in its catalytic kinase domain.

Bhavnani, Varsha, Kaviraj, Swarnendu, Panigrahi, Priyabrata, Suresh, C.G., Yapara, SuneelShekar, Pal, Jayanta

This result is not displayed to guests.
Login for full access.